ATP13A2 and Parkinson disease: Recent work showed that acidic nanoparticles were able to stimulate lysosomal degradation by the lowering of lysosomal pH [144], reverting lysosomal dysfunction in three different PD genetic models, including ATP13A2-mutant cells and GBA-mutant cells [145].